Dr Reddy’s Laboratories (RDY) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Dr. Reddy’s Laboratories Ltd. has announced that its shareholders approved the subdivision of its equity shares through a postal ballot, with the results demonstrating a favorable outcome from the voting process. Each equity share with a face value of Rs. 5 will be split into five shares with a face value of Re. 1, also requiring an alteration to the company’s Memorandum of Association. The detailed voting report has been made publicly accessible on the company’s website.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.